- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
EpCAM antibody detects epithelial cell adhesion molecule, a transmembrane glycoprotein encoded by the EPCAM gene. EpCAM is expressed broadly in epithelial tissues and is frequently upregulated in epithelial-derived tumors. The molecule contributes to intercellular adhesion, cellular proliferation, and signaling cascades that influence development and oncogenesis. Because EpCAM expression is widespread in carcinomas, EpCAM antibody has become an indispensable marker in oncology and epithelial biology.
EpCAM structure consists of an extracellular domain, a single transmembrane helix, and a short intracellular tail. The extracellular portion mediates homophilic cell adhesion, while the cytoplasmic region interacts with adaptor proteins that regulate signaling. Proteolytic cleavage of EpCAM can release its intracellular domain, which enters the nucleus and modulates transcription of genes linked to proliferation. This dual role in adhesion and transcriptional regulation underscores the importance of EpCAM in both physiology and pathology.
In healthy tissues, EpCAM maintains epithelial integrity and polarity. In cancer, however, EpCAM is frequently overexpressed and redistributed, correlating with tumor progression and poor prognosis. It is studied in colorectal, breast, ovarian, and pancreatic carcinomas, where its presence helps classify tumors and assess aggressiveness. Research also shows that EpCAM supports cancer stem cell properties, linking it to therapy resistance and tumor recurrence.
The EpCAM antibody clone rEGP40/7334 provides reproducible and specific detection of this protein. Recombinant production ensures uniform performance across lots, making clone rEGP40/7334 dependable for long-term projects. Peer-reviewed studies have employed EpCAM antibodies in cancer classification, stem cell research, and translational studies aimed at antibody-based therapeutics. This clone is suited to both basic and applied investigations where EpCAM detection is critical.
Research using clone rEGP40/7334 has clarified how EpCAM expression patterns distinguish carcinoma subtypes and guide patient management. Its detection has also contributed to the development of targeted therapies, including monoclonal antibodies and CAR T cell approaches designed to selectively recognize EpCAM-positive tumors. Because EpCAM is largely absent from non-epithelial tissues, it offers a level of tumor specificity that supports therapeutic exploration. Publications have documented its value in defining tumor biology and supporting precision medicine strategies.
Beyond oncology, EpCAM is relevant in developmental and stem cell biology. It marks epithelial progenitors and is used to isolate stem cell populations for regenerative studies. This highlights its dual importance as both a cancer marker and a developmental regulator. Detection with clone rEGP40/7334 continues to provide insight into epithelial lineage biology and tumor pathogenesis.
NSJ Bioreagents supplies this EpCAM antibody to support studies in oncology, stem cell research, and therapeutic development. Alternate names include epithelial cell adhesion molecule antibody, ESA antibody, TACSTD1 antibody, tumor-associated calcium signal transducer 1 antibody, epithelial tumor marker antibody, and EpCAM glycoprotein antibody.
Optimal dilution of the EpCAM antibody should be determined by the researcher.
Recombinant full-length human protein was used as the immunogen for the EpCAM antibody.
Aliquot the EpCAM antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.